| dc.contributor.author | Taran, Anatolie | |
| dc.date.accessioned | 2019-06-07T09:41:00Z | |
| dc.date.available | 2019-06-07T09:41:00Z | |
| dc.date.issued | 2017 | |
| dc.identifier.citation | TARAN, Anatolie. Unele particularităţi epidemiologice şi managementul antibioticoterapiei infecţiilor septico-purulente în endoprotezarea articulaţiilor coxofemurale şi de genunchi. In: Sănătate Publică, Economie şi Management în Medicină. 2017, nr. 3(73), pp. 21-24. ISSN 1729-8687. | en_US |
| dc.identifier.issn | 1729-8687 | |
| dc.identifier.uri | https://repository.usmf.md/handle/20.500.12710/1366 | |
| dc.identifier.uri | http://revistaspemm.md/wp-content/uploads/2019/04/cm3_73_2017cg-2.pdf | |
| dc.description | Catedra Ortopedie şi Traumatologie, IP USMF Nicolae Testemiţanu | en_US |
| dc.description.abstract | Some epidemiologic particularities and management of treatment with antibiotics of septic-purulent infections of hip and knee joints endoprosthesis Analyzing medical records of patients with endoprosthesis treated in the orthopaedic departments of PMSI CHTO, during 2011- 2015, showed various septic-purulent complications in 37 (5.36%) patients hospitalized in the department of septic surgery. However, analyzing the prosthesis patients with various septic-purulent infections, we found that the incubation period is on average about 18 months. As a result of bacteriological study, 33 bacterial strains were detected, which demonstrates the polyetiologic nature of nosocomial infections. In 40% of those investigated, were found 2 to 3 strains of bacteria. The total resistance to all groups of antibiotics was observed in 28.6% of cases, sensitivity – 71.4%. Descriptive study examines the incidence of nosocomial infections declared, but also those undeclared by a retrospective review of medical records. Septic-purulent infections were found in 5.36% cases for 100 surgeries. Mainly Gram-positive infections, which represented 75.75% of the total number of microorganisms detected, Gram negative – 24.25%, S. epidermidis, S. aureus, S. hemoliticus, P. aeroginosa, E. coli. A better sensitivity to antibiotics were found in microorganisms of Staphylococcus and Streptococcus genus, including S. aureus (91.82%), S. epidermidis (76%), S. aeroginosa (85.7), Acinetobacter (75%), E. coli (31.3%), P. aeroginosa (16%). | en_US |
| dc.language.iso | ro | en_US |
| dc.publisher | Asociația Obștească "Economie, Management și Psihologie în Medicină" din Republica Moldova | en_US |
| dc.relation.ispartof | Sănătate Publică, Economie şi Management în Medicină: Al III-lea Congres al medicilor interniști din Republica Moldova cu participare internațională 24–25 octombrie 2017 Chișinău, Republica Moldova | |
| dc.subject | septic-purulent nosocomial infections and endoprosthesis | en_US |
| dc.subject | epidemiological particularities | en_US |
| dc.subject | risk factors | en_US |
| dc.subject | resistance to antibiotics | en_US |
| dc.subject | epidemiological surveillance and control | en_US |
| dc.subject.ddc | CZU: 616.5-089.844 (076) | |
| dc.subject.mesh | Bacterial Infections--epidemiology | en_US |
| dc.subject.mesh | Arthroplasty, Replacement, Hip | en_US |
| dc.subject.mesh | Hip Prosthesis | en_US |
| dc.subject.mesh | Arthroplasty, Replacement, Knee | en_US |
| dc.subject.mesh | Knee Prosthesis | en_US |
| dc.subject.mesh | Bacterial Infections--drug therapy | en_US |
| dc.subject.mesh | Cross Infection--epidemiology | en_US |
| dc.subject.mesh | Cross Infection--drug therapy | en_US |
| dc.subject.mesh | Anti-Bacterial Agents--therapeutic use | en_US |
| dc.subject.mesh | Risk Factors | en_US |
| dc.subject.mesh | Drug Resistance, Bacterial | en_US |
| dc.title | Unele particularităţi epidemiologice şi managementul antibioticoterapiei infecţiilor septico-purulente în endoprotezarea articulaţiilor coxofemurale şi de genunchi | en_US |
| dc.title.alternative | Some epidemiologic particularities and management of treatment with antibiotics of septic-purulent infections of hip and knee joints endoprosthesis | en_US |
| dc.type | Article | en_US |